Mylan

Yupelri

Manufacturer:

Mylan

Yupelri HCPCS:

J7677

HCPCS Code Descriptor:

Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram

Category:

J Code

Yupelri NDCs:

49502-0806-93

Primary Type:

Respiratory

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Inhalation

Yupelri CPT Codes:

Potential CPT administration codes for Yupelri can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Yupelri:

Yupelri is a Respiratory drug manufactured by Mylan and administered via the Inhalation route of administration. The J Code: J7677 is aligned to the drug Yupelri.

ACCESS PRICING AND MORE BY REGISTERING

J7677 Added Date:

July 1, 2019

J7677 Effective Date:

July 1, 2019

J7677 Termination Date:

HCPCS Active

Yupelri billing and coding information can be found through Mylan at the link below:
Yupelri patient assistance information can be found through Viatris Patient Assistance Program at the URL: https://www.viatris.com/en-us/lm/united-states/patient-assistance-program
Yupelri prescribing information can be found at the link below:
Information regarding Yupelri’s side effects can be found at MedlinePlus